Related references
Note: Only part of the references are listed.IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint Inhibition
Louise W. Treffers et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis
Merav E. Shaul et al.
FASEB JOURNAL (2020)
IgA subclasses have different effector functions associated with distinct glycosylation profiles
Ulrike Steffen et al.
NATURE COMMUNICATIONS (2020)
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling
A. Romano et al.
SCIENTIFIC REPORTS (2020)
A multicentre, randomised trial comparing schedules of G-CSF ( fi lgrastim) administration for primary prophylaxis of chemotherapy -induced febrile neutropenia in early stage breast cancer
M. Clemons et al.
ANNALS OF ONCOLOGY (2020)
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
Cristina Perez et al.
BLOOD (2020)
There Is (Scientific) Strength in Numbers: A Comprehensive Quantitation of Fc Gamma Receptor Numbers on Human and Murine Peripheral Blood Leukocytes
Christina Kerntke et al.
FRONTIERS IN IMMUNOLOGY (2020)
Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer
Guanghui Zhao et al.
MEDICINE (2020)
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Kurt A. Schalper et al.
NATURE MEDICINE (2020)
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe C. Yuen et al.
NATURE MEDICINE (2020)
Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
Huan Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis
Rui Sun et al.
TRANSLATIONAL ONCOLOGY (2020)
The identification of a CD47-blocking hotspot and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
Rui Shi et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells o severe congenital neutropenia patients
Masoud Nasri et al.
HAEMATOLOGICA (2020)
Anti-TGF-beta attenuates tumor growth via polarization of tumor associated neutrophils towards an anti-tumor phenotype in colorectal cancer
Fengxian Qin et al.
JOURNAL OF CANCER (2020)
Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
Christine Haider et al.
HEPATOLOGY (2019)
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Branimir Sikic et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Orchestration of Adaptive T Cell Responses by Neutrophil Granule Contents
Danielle Minns et al.
MEDIATORS OF INFLAMMATION (2019)
Highly efficient therapeutic gene editing of human hematopoietic stem cells
Yuxuan Wu et al.
NATURE MEDICINE (2019)
Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis
Yuan He et al.
NATURE COMMUNICATIONS (2019)
Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity
Juan J. Miret et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells (vol 38, pg 6, 2019)
Sen Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
Quentin Haas et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Distinct Fcα receptor N-glycans modulate the binding affinity to immunoglobulin A (IgA) antibodies
Kathrin Goeritzer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
High expression of CD47 in triple negative breast cancer is associated with epithelial-mesenchymal transition and poor prognosis
Jingping Yuan et al.
ONCOLOGY LETTERS (2019)
Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver Metastasis
Brian E. Hsu et al.
CELL REPORTS (2019)
Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG
Arianne M. Brandsma et al.
FRONTIERS IN IMMUNOLOGY (2019)
A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients
Tao Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
The potential role of neutrophil trogocytosis and G-CSF in the loss of HER2 expression
Z. Strizova et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL
Renee Bouwstra et al.
CANCER IMMUNOLOGY RESEARCH (2019)
TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors
Marion V. Guerin et al.
NATURE COMMUNICATIONS (2019)
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Maria Teresa Masucci et al.
FRONTIERS IN ONCOLOGY (2019)
Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation
Josee Golay et al.
BLOOD (2019)
Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation
Eric Hatterer et al.
MABS (2019)
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint
Erik Voets et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils
Louise W. Treffers et al.
FRONTIERS IN IMMUNOLOGY (2019)
DSP107-a novel SIRPα-4-1BBL dual signaling protein (DSP) for cancer immunotherapy
Yosi M. Gozlan et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Targeting CD47 in Sezary syndrome with SIRPαFc
Lisa D. S. Johnson et al.
BLOOD ADVANCES (2019)
Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses
Boning Liu et al.
MABS (2018)
CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy
Bingyu Li et al.
ONCOIMMUNOLOGY (2018)
CD20-selective inhibition of CD47-SIRP alpha don't eat me signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab
Peter E. van Bommel et al.
ONCOIMMUNOLOGY (2018)
Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC
Marion Humbert et al.
CANCER RESEARCH (2018)
Tumor-associated neutrophils correlate with poor prognosis in diffuse large B-cell lymphoma patients
B. Manfroi et al.
BLOOD CANCER JOURNAL (2018)
Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer
Zhiwei Liu et al.
SCIENTIFIC REPORTS (2018)
Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
Hanke L. Matlung et al.
CELL REPORTS (2018)
Tumor-associated neutrophils suppress protumoral IL-17+γδ T cells through induction of oxidative stress
Sofia Mensurado et al.
PLOS BIOLOGY (2018)
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
Michal A. Stanczak et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion
Xiaojuan Liu et al.
CELL REPORTS (2018)
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
Ranjana Advani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Mesenchymal Stromal Cells Inhibit Neutrophil Effector Functions in a Murine Model of Ocular Inflammation
Sharad K. Mittal et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody-dependent cellular cytotoxicity towards cancer cells
Louise W. Treffers et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Heterogeneity Among Neutrophils
Marzena Garley et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)
Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
Jane Margetts et al.
BRITISH JOURNAL OF CANCER (2018)
Neutrophil Suppresses Tumor Cell Proliferation via Fas/Fas Ligand Pathway Mediated Cell Cycle Arrested
Bingwei Sun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity
Stefan Lohse et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience
Claudio Cerchione et al.
SUPPORTIVE CARE IN CANCER (2017)
NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC
Camilla Rydberg Millrud et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
Umberto Vitolo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
Elie Dheilly et al.
MOLECULAR THERAPY (2017)
Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence
Jingwei Xue et al.
NATURE NANOTECHNOLOGY (2017)
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
R. Marcus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Large-scale ex vivo generation of human neutrophils from cord blood CD34+ cells
Zhenwang Jie et al.
PLOS ONE (2017)
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
Nan Guo Ring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo
Bingyu Li et al.
ONCOTARGET (2017)
Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
Gillian Dekkers et al.
FRONTIERS IN IMMUNOLOGY (2017)
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
Liang Liu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion
Sophie Laget et al.
PLOS ONE (2017)
High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer
Ryan S. Berry et al.
PLOS ONE (2017)
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab
Jakub Krejcik et al.
CLINICAL CANCER RESEARCH (2017)
Always Look On the Bright Side: Anti-Tumor Functions of Neutrophils
Sandra Vols et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
Valeria Governa et al.
CLINICAL CANCER RESEARCH (2017)
Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration
Dafeng Chu et al.
ADVANCED MATERIALS (2017)
Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation
Anel Lizcano et al.
BLOOD (2017)
Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies
Rut Valgardsdottir et al.
BLOOD (2017)
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Ting Kang et al.
ACS NANO (2017)
An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo
Stefan Lohse et al.
CANCER RESEARCH (2016)
Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human
Lisa Andzinski et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting
Saskia Meyer et al.
MABS (2016)
The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia
Justyna Rybka et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer
Sunil Singhal et al.
CANCER CELL (2016)
Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients
Sumita Trivedi et al.
CLINICAL CANCER RESEARCH (2016)
Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer
Maria Rosaria Galdiero et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Low expression of Toll-like receptors in peripheral blood mononuclear cells of pediatric patients with acute lymphoblastic leukemia
Maria Sanchez-Cuaxospa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
Kipp Weiskopf et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Pegfilgrastim Enhances the Antitumor Effect of Therapeutic Monoclonal Antibodies
Sebastien Cornet et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunity
Chin Yang Chang et al.
ONCOTARGET (2016)
Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy
Dafeng Chu et al.
ADVANCED HEALTHCARE MATERIALS (2016)
The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils
Ekaterina Pylaeva et al.
FRONTIERS IN IMMUNOLOGY (2016)
Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs
Merav E. Shaul et al.
ONCOIMMUNOLOGY (2016)
TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients
Elizabeth Comen et al.
NPJ BREAST CANCER (2016)
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
Gaixia He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells
Emily C. Piccione et al.
MABS (2015)
C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity
Valerie R. Wiersma et al.
MABS (2015)
Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding
M. Jack Borrok et al.
MABS (2015)
MET is required for the recruitment of anti-tumoural neutrophils
Veronica Finisguerra et al.
NATURE (2015)
Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils
Amy-Jo Casbon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Neutrophil trails guide influenza-specific CD8+ T cells in the airways
Kihong Lim et al.
SCIENCE (2015)
Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer
Jitka Y. Sagiv et al.
CELL REPORTS (2015)
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing
Arianne M. Brandsma et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Isolation and Characterization of Neutrophils with Anti-Tumor Properties
Ronit Vogt Sionov et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Programming of the Development of Tumor-Promoting Neutrophils by Mesenchymal Stromal Cells
Xiaoyu Hu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β
J. Jablonska et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Evgeniy B. Eruslanov et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity
Stefanie Derer et al.
MABS (2014)
Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
Meixiao Shen et al.
PLOS ONE (2014)
Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients
Wen-Chao Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer
Heinz Laubli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Restricted Motion of the Conserved Immunoglobulin G1 N-Glycan Is Essential for Efficient FcγRIIIa Binding
Ganesh P. Subedi et al.
STRUCTURE (2014)
Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells
Jun Yan et al.
ONCOIMMUNOLOGY (2014)
ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils
Yue Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Neutrophils mediate antibody-induced antitumor effects in mice
Marcello Albanesi et al.
BLOOD (2013)
Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab
Josee Golay et al.
BLOOD (2013)
Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab
Edmund A. Rossi et al.
BLOOD (2013)
IgA EGFR antibodies mediate tumour killing in vivo
Peter Boross et al.
EMBO MOLECULAR MEDICINE (2013)
Binding of the Sialic Acid-binding Lectin, Siglec-9, to the Membrane Mucin, MUC1, Induces Recruitment of β-Catenin and Subsequent Cell Growth
Shuhei Tanida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy
Luca Bologna et al.
JOURNAL OF IMMUNOLOGY (2013)
Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression
M. A. Lopez-Lago et al.
ONCOGENE (2013)
Transforming Growth Factor-β1 and -β2 in Gastric Precancer and Cancer and Roles in Tumor-Cell Interactions with Peripheral Blood Mononuclear Cells In Vitro
Gui-Fen Ma et al.
PLOS ONE (2013)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
Significance of serum tumor necrosis factor-related apoptosis-inducing ligand as a prognostic biomarker for renal cell carcinoma
Daisuke Toiyama et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Endocytosis of soluble immune complexes leads to their clearance by FcγRIIIB but induces neutrophil extracellular traps via FcγRIIA in vivo
Kan Chen et al.
BLOOD (2012)
Analysis of Fcγ Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer Patients
Sara A. Hurvitz et al.
CLINICAL CANCER RESEARCH (2012)
Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells
Virginie Pascal et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Neutrophils sustain effective CD8+ T-cell responses in the respiratory tract following influenza infection
Michelle D. Tate et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Neutrophils Mediate Maturation and Efflux of Lung Dendritic Cells in Response to Aspergillus fumigatus Germ Tubes
Stacy J. Park et al.
INFECTION AND IMMUNITY (2012)
5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane Potential
Daniel Prantner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Impact of Epidermal Growth Factor Receptor (EGFR) Cell Surface Expression Levels on Effector Mechanisms of EGFR Antibodies
Stefanie Derer et al.
JOURNAL OF IMMUNOLOGY (2012)
T Lymphocyte Priming by Neutrophil Extracellular Traps Links Innate and Adaptive Immune Responses
Kati Tillack et al.
JOURNAL OF IMMUNOLOGY (2012)
Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells
De-Kuan Chang et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Influenza-Infected Neutrophils within the Infected Lungs Act as Antigen Presenting Cells for Anti-Viral CD8+ T Cells
Matthew M. Hufford et al.
PLOS ONE (2012)
Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients
Rachael A. Clark et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients
Jana de Boniface et al.
ONCOIMMUNOLOGY (2012)
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung
Zvi Granot et al.
CANCER CELL (2011)
IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3)
Karen M. Henkels et al.
FEBS LETTERS (2011)
FcγRIIIb Triggers Raft-dependent Calcium Influx in IgG-mediated Responses in Human Neutrophils
Louis Marois et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lung Neutrophils Facilitate Activation of Naive Antigen-Specific CD4+ T Cells during Mycobacterium tuberculosis Infection
Robert Blomgran et al.
JOURNAL OF IMMUNOLOGY (2011)
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction
Xi Wen Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose
Claudia Ferrara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia
Nobuo Kuninaka et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
Granulocytes as effective anticancer agent in experimental solid tumor models
Morana Jaganjac et al.
IMMUNOBIOLOGY (2010)
Neutrophils responsive to endogenous IFN-β regulate tumor angiogenesis and growth in a mouse tumor model
Jadwiga Jablonska et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage
Tanja Schneider-Merck et al.
JOURNAL OF IMMUNOLOGY (2010)
A Recombinant Bispecific Single-Chain Fragment Variable Specific for HLA Class II and FcαRI (CD89) Recruits Polymorphonuclear Neutrophils for Efficient Lysis of Malignant B Lymphoid Cells
Yvonne Guettinger et al.
JOURNAL OF IMMUNOLOGY (2010)
Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models
William M. Siders et al.
LEUKEMIA & LYMPHOMA (2010)
Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions
Gregory L. Moore et al.
MABS (2010)
Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution
Colleen Delaney et al.
NATURE MEDICINE (2010)
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
Marcin Kowanetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Antiproliferative Properties of Type I and Type II Interferon
Joseph Bekisz et al.
PHARMACEUTICALS (2010)
Role of GM-CSF signaling in cell-based tumor immunization
Shohreh Zarei et al.
BLOOD (2009)
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns et al.
BLOOD (2009)
The Yin-Yang of Tumor-Associated Neutrophils
Alberto Mantovani
CANCER CELL (2009)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils
Mami Shibata-Koyama et al.
EXPERIMENTAL HEMATOLOGY (2009)
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
Yanping Hu et al.
IMMUNOLOGY (2009)
Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells
Estrella Mariel Levy et al.
INNATE IMMUNITY (2009)
Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
Frederic Bibeau et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Dynamics of the Interaction of Human IgG Subtype Immune Complexes with Cells Expressing R and H Allelic Forms of a Low-Affinity Fcγ Receptor CD32A
Rangaiah Shashidharamurthy et al.
JOURNAL OF IMMUNOLOGY (2009)
Human Basophils Express the Glycosylphosphatidylinositol-Anchored Low-Affinity IgG Receptor FcγRIIIB (CD16B)
Nihad Meknache et al.
JOURNAL OF IMMUNOLOGY (2009)
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Matthias Peipp et al.
BLOOD (2008)
The involvement of granulocytes in spontaneous regression of Walker 256 carcinoma
Morana Jaganjac et al.
CANCER LETTERS (2008)
Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice
Celine Morel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Murine neutrophils present Class II restricted antigen
Shauna Culshaw et al.
IMMUNOLOGY LETTERS (2008)
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
Antonino Musolino et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses
Gonzalo De la Rosa et al.
JOURNAL OF IMMUNOLOGY (2008)
Neutrophils efficiently cross-prime naive T cells in vivo
Celine Beauvillain et al.
BLOOD (2007)
Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptor
Michael Dechant et al.
JOURNAL OF IMMUNOLOGY (2007)
FCGR2A and FCGR3A Polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab
Wu Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Combined yeast β-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55
Bing Li et al.
CANCER RESEARCH (2007)
Inhibition of human neutrophil degranulation by transforming growth factor-β1
L. Shen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity
Heike Horner et al.
JOURNAL OF IMMUNOLOGY (2007)
Pharmacogenomic analysis of a randomized phase II trial (BOND 2) of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
W. Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Expression profile of FcγRIIB on leusocytes and its dysregulation in systemic lupus erythematosus
Kaihong Su et al.
JOURNAL OF IMMUNOLOGY (2007)
Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate
Jodie M. Challacombe et al.
JOURNAL OF IMMUNOLOGY (2006)
Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes
Anna Maria Megiovanni et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress
VP Makarenkova et al.
JOURNAL OF IMMUNOLOGY (2006)
Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L
TJ Kemp et al.
BLOOD (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and β-Glucan
DJ Allendorf et al.
JOURNAL OF IMMUNOLOGY (2005)
Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors
MA Otten et al.
JOURNAL OF IMMUNOLOGY (2005)
Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN
KPJM van Gisbergen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Identification of Fc alpha RI as an inhibitory receptor that controls inflammation: Dual role of FcR gamma ITAM
B Pasquier et al.
IMMUNITY (2005)
Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): A novel mechanism of antitumor effect by neutrophils
Y Koga et al.
CANCER RESEARCH (2004)
Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils
H Kamohara et al.
IMMUNOLOGY (2004)
Human neutrophils produce interferon gamma upon stimulation by interleukin-12
F Ethuin et al.
LABORATORY INVESTIGATION (2004)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8
JE De Larco et al.
CLINICAL CANCER RESEARCH (2004)
Mechanism by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models
F Hong et al.
JOURNAL OF IMMUNOLOGY (2004)
IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells
C Tecchio et al.
BLOOD (2004)
Tumor necrosis factor-related apoptosis-inducing ligand: A novel mechanism for Bacillus Calmette-Guerin-induced antitumor activity
AT Ludwig et al.
CANCER RESEARCH (2004)
Cross-talk in the innate immune system: Neutrophils instruct recruitment and activation of dendritic cells during microbial infection
S Bennouna et al.
JOURNAL OF IMMUNOLOGY (2003)
Activated neutrophils exert antitumor activity against human melanoma cells: Reactive oxygen species-induced mechanisms and their modulation by granulocyte-macrophage-colony-stimulating factor
J Dissemond et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF:: final report on safety and efficacy
LE van der Kolk et al.
LEUKEMIA (2003)
TGF-β1 supresses myeloid Fcγ receptor function by regulating the expression and function of the common γ-subunit
S Tridandapani et al.
JOURNAL OF IMMUNOLOGY (2003)
Bivalent binding of IgA1 to FcαRI suggests a mechanism for cytokine activation of IgA phagocytosis
AB Herr et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation
M Shigeno et al.
ONCOGENE (2003)
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid
N Donin et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Acceleration of human neutrophil apoptosis by TRAIL
SA Renshaw et al.
JOURNAL OF IMMUNOLOGY (2003)
Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
WK Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Elevated serum arginase activity levels in patients with breast cancer
MF Polat et al.
SURGERY TODAY (2003)
Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing
M Dechant et al.
BLOOD (2002)
Analysis of CD20-dependent cellular cytotoxicity by G-CSF-stimulated neutrophils
LE van der Kolk et al.
LEUKEMIA (2002)
Signal regulatory protein (SIRPα), a cellular ligand for CD47, regulates neutrophil transmigration
Y Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The role of CD47 in neutrophil transmigration - Increased rate of migration correlates with increased cell surface expression of CD47
Y Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma
M Wislez et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes
NS Potter et al.
JOURNAL OF IMMUNOLOGY (2001)
Differential activation of TRAIL-R1 and-2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative
H Wajant et al.
ONCOGENE (2001)
Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia
K Tateda et al.
JOURNAL OF IMMUNOLOGY (2001)
Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies
B Stockmeyer et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Bispecific antibody-mediated destruction of Hodgkin's lymphoma cells
K Sundarapandiyan et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Polymorphonuclear neutrophils as accessory cells for T-cell activation:: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation
M Radsak et al.
IMMUNOLOGY (2000)
Triggering FCα-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy
B Stockmeyer et al.
JOURNAL OF IMMUNOLOGY (2000)
Concurrent binding to multiple ligands: Kinetic rates of CD16b for membrane-bound IgG1 and lgG2
TE Williams et al.
BIOPHYSICAL JOURNAL (2000)
Share Paper
